President Trump wants a drug to treat coronavirus infection to be found quickly even it existed before. He directed the FDA to investigate whether an existing drug for malaria can be used.
It’s about the anti-malaria drug hydroxychloroquine, developed over half a century ago. At this moment there are no proven therapies for the COVID-19 virus, which has rapidly grown into a pandemic. A vaccine ready for public use could take 12 to 18 months. It is important “not to provide false hope,” FDA Commissioner Stephen Hahn said about chloroquine. The World Health Organization said last month that there is “no proof” the drug is effective in treating the coronavirus. But“(w)e predict that the drug has a good potential to combat the disease,” many researchers from the Chinese Academy of Sciences in Wuhan affirmed in a letter published in Cell Discovery on Wednesday.
The researchers found that 50 percent of the treated group turned from positive to negative for the virus by the third day. Some health authorities in the U.S. and China have been using Gilead Sciences’ antiviral medication Remdesivir, which was tested as a possible treatment for the Ebola outbreak. Antiviral drug Kaletra, developed by drugmaker AbbVie, has also been used by some authorities. First coronavirus vaccine trial began in the US.